COGT Cogent Biosciences Inc reports wider Q4 2025 loss than consensus analyst estimates with shares dipping 036 percent in todays trading CNR Core Natural Q1 EPS beats estimates by 15 revenue surges 92 yearoveryear shares fall 4 Why Weis Markets WMK could be the anchor your portfolio needs Hovering 20260510 DBRGH DigBridge H Series H yield draws income investors despite limited quarterly disclosure parent DigitalBridge reports results Kymera Therapeutics KYMR Stock Interest Rate Modest Uptick 20260418 Enhabit EHAB Moat Analysis Q4 2025 Earnings Fall Short Myers Industries MYE Stock Income Play Trades Lower 20260415 Broadridge BR Operational Review Q1 2026 Profit Surprises The hidden strength in Virtus NCZ most investors miss Momentum Building 20260508 Garden Pet CENT Stock Overvalued Grinds Higher 20260415 KVHI KVH Industries EPS crushes estimates with 296 surprise yet revenue decline and 3 stock slide signal investor caution NAGE Niagen Bioscience Inc reports solid Q4 2025 EPS beat and nearly 30 percent year over year revenue growth stock rises modestly